![](https://visiopharm.com/wp-content/uploads/thumbnail-webinar-improving-diagnostic-workflows-with-ai.png)
![](https://visiopharm.com/wp-content/uploads/thumbnail-webinar-improving-diagnostic-workflows-with-ai.png)
Analyzing slides for lymph node metastasis detection is tedious and time-consuming. What if you could automate your workload without sacrificing accuracy?
In this webinar Dr. Stine Harder and Dzenita Omanovic will introduce the first multi-indication AI-assisted, CE-IVD Metastasis Detection APP. Using data from two studies which compare the standard practice of assessing metastasis-status in lymph nodes by manual scoring with an AI-based image analysis approach for breast and colon carcinoma, they will showcase how this APP performs in a clinical setting.
Find out how you can use this APP to efficiently order, identify, and assess metastasis in lymph nodes.
-
- How to improve your detection sensitivity of metastatic regions compared to current standards
-
- How to save time with automated slide sorting to select the slides you want to review first
-
- How to easily integrate this APP into your diagnostic workflow
![](https://visiopharm.com/wp-content/uploads/Stine-Harder-190x233-1.jpg)
Stine Harder, PhD, Head of Clinical Product Management, Visiopharm
Stine’s passion is image analysis and she continued her research during a 2-year postdoc tenure. She has a Ph.D. in Image Analysis from the Technical University of Denmark. In her current position, Stine oversees the complete lifecycle of Visiopharm’s clinical products
![](https://visiopharm.com/wp-content/uploads/Woman-190x233-1.png)
Dzenita Omanovic, Image Analysis Specialist, Visiopharm
Dzenita is highly skilled in CE-IVD apps and data sourcing and management. She specializes in external collaborations and projects of the clinical CE-IVD or future FDA scope.
Please note, Dzenita Omanovic no longer works at Visiopharm.